Impact of generic competition on market share and prices of cardiovascular medicines on the Bulgarian pharmaceutical market

Abstract: Background: During the last three decades tremendous progress has been made in the discovery and development of a lot of new molecules in many pharmaceutical areas. These families of real innovative treatment comprise "originator" molecules (first molecule released, which can be under patent or with expired patent), as well a "generic" version of those originator molecules, whose patent has expired. Usually the patent expires 15–20 years after the creation of the originator molecule. Main objective: This research focuses on the effects of the arrival of generic and or therapeutic competitors on the market, in terms of impact on the market share and prices. Methodology: Between 2005 and 2007 we follow three classes of medicinal products in the cardiovascular area: ACE inhibitors, sartans and statins. They have been studied on the Bulgarian market because there is no regulation in the country stimulating the generic market. The official database of the Bulgarian Health Insurance Fund

Angaben zum Objekt

• Standort: Deutsche Nationalbibliothek Frankfurt am Main
• Umfang: Online-Ressource
• Sprache: Englisch
• Anmerkungen: Postprint ; begutachtet (peer reviewed) ; In: Journal of Public Health ; 19 (2010) 1 ; 91-100

Klassifikation und Themen

• Klassifikation: Wirtschaft

Beteiligte, Orts- und Zeitangaben

• Ereignis: Veröffentlichung
• (wo): Mannheim
• (wann): 2010
• Urheber: Manova, Manoela M. ; Stoimenova, Assena ; Clerfeuille, Fabrice ; Petrova, Guenka I.

Weitere Informationen

• DOI: 10.1007/s10389-010-0352-8
• URN: urn:nbn:de:0168-ssoar-214064
• Rechteinformation: Open Access unbekannt; Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Letzte Aktualisierung: 15.08.2025, 07:25 MESZ